Regenerative Medicine

Regenerative medicine is an umbrella term used for treatments intended to support tissue recovery, improve the biologic environment and restore function.

The term is also used loosely. Treatments with different sources, mechanisms and levels of evidence are often presented as though they were interchangeable.

This page explains what regenerative medicine means at Nucellin Orthopedic Clinic, which treatments sit under the term and how we decide whether one of them is appropriate.

On this page

1. What regenerative medicine is
2. How it works
3. What treatments sit under the term
4. What happens, step by step
5. Recovery timeline
6. Whether it suits you
7. Questions patients ask

What Regenerative Medicine Is

One of the most common misconceptions about regenerative medicine is that it can simply replace damaged tissue.

Patients may imagine new cartilage, a completely restored tendon or a joint returned to its original condition. Current non-surgical treatments cannot reliably produce those outcomes.

In chronic musculoskeletal conditions, the problem is rarely limited to one damaged structure.

By the time many patients seek treatment, the body may already have spent months or years adapting through:

• Altered movement
• Muscular compensation
• Protective guarding
• Redistribution of load
• Reduced activity
• Changes in inflammatory signalling
• Increased sensitivity around the painful area

These adaptations may initially help protect the body. Over time, however, they can become inefficient and limit function.

At Nucellin, regenerative medicine is therefore not defined as the construction of completely new tissue.

It is a clinical approach intended to:

• Identify the true pain-generating structure
• Reduce excessive tissue irritation
• Improve the local biologic environment
• Restore movement and load tolerance
• Support rehabilitation
• Help the patient return to meaningful activity

The goal is not perfection.

The goal is better adaptation, function and tissue capacity.

Why Imaging Never Explains Everything

Two people can have similar findings on X-ray or MRI and experience very different symptoms.

One may remain active and functional. The other may develop pain, repeated flare-ups and progressive limitation.

Imaging can show:

• Cartilage loss
• Tendon abnormalities
• Disc degeneration
• Meniscal or labral changes
• Bone and joint structure

It does not directly measure:

• Pain
• Muscle capacity
• Movement control
• Nervous-system sensitivity
• Inflammatory activity
• Confidence in movement
• Tolerance for work, exercise and daily load

This does not make imaging unimportant.

It means that imaging must be interpreted together with the patient’s symptoms, physical examination and functional limitations.

An image is evidence. It is not the diagnosis by itself.

What Regenerative Medicine Is Not

Regenerative orthopedic medicine is not the same as general wellness, anti-ageing treatment or intravenous optimisation therapy.

Our focus is musculoskeletal function.

The purpose is not simply to help someone feel temporarily more energised. It is to address a clearly identified joint, tendon, ligament, muscle, nerve-related or other musculoskeletal problem.

Regenerative treatment is also not automatically the most advanced or appropriate treatment.

Some patients need:

• Rehabilitation
• Load modification
• Temporary protection
• Mechanical stabilisation
• Medication
• Conventional surgery
• Joint replacement
• Time and appropriate guidance

Knowing when not to perform a regenerative procedure is part of responsible treatment.

How It Works

A painful joint or tissue can be compared to a system under stress.

The structural abnormality may be visible, but the symptoms also depend on whether the surrounding muscles, nervous system and tissues can continue adapting to the load placed on them.

Treatment therefore begins by asking:

• Is the condition acute or chronic?
• Is the tissue still highly irritable?
• Is the problem primarily mechanical, biologic or neurologic?
• Is there a clearly identifiable treatment target?
• Is the joint stable?
• Is there a complete tear, severe compression or another condition requiring surgery?
• Can the patient participate in rehabilitation?
• What level of load can the tissue currently tolerate?

The procedure is only one part of the treatment.

Three Common Clinical Patterns

Patients with similar imaging may need different treatment because their clinical state is different.

1. The Tissue Is Not Ready for Higher Load

The area may be acutely painful, swollen, guarded or unable to tolerate basic movement.

The initial priority may be to:

• Reduce irritation
• Protect the injured structure
• Control excessive swelling
• Maintain safe movement
• Restore basic stability

A biologic procedure is not automatically the first step.

2. The System Is Overloaded

The tissue may tolerate some activity but repeatedly become painful because load is being distributed inefficiently.

Treatment may focus on:

• Modifying repetitive load
• Improving muscle capacity
• Correcting movement strategy
• Treating surrounding soft-tissue overload
• Gradually rebuilding tolerance

3. There Is a Specific Local Target

Some patients have a clear anatomical pain generator supported by examination and imaging.

A targeted procedure may then be considered as part of the treatment plan.

The first question is therefore not:

“What should we inject?”

It is:

“What is generating the symptoms, and what can this tissue tolerate now?”

Treatment Is Sequenced, Not Simply Added

More treatment does not necessarily produce a better result.

An injection or cell-based procedure performed before the diagnosis is clear, while severe instability remains present or without an appropriate rehabilitation plan may provide limited benefit.

The sequence may include:

1. Identifying the pain generator
2. Reducing excessive irritation
3. Restoring safe movement
4. Performing a targeted procedure when appropriate
5. Gradually rebuilding strength and load tolerance
6. Reassessing the clinical response

The sequence differs according to the diagnosis.

What Treatments Sit Under the Term

Regenerative medicine is an umbrella rather than one procedure.

At Nucellin Orthopedic Clinic, the broader regenerative approach may include biologic treatment, targeted injection treatment and rehabilitation-based treatment.

Each option has a different purpose.

Activated PRF Therapy

Activated platelet-rich fibrin is prepared from the patient’s own blood.

It is a platelet- and fibrin-based treatment intended to create a supportive biologic environment around a carefully selected treatment target.

Activated PRF is not identical to conventional PRP. The blood volume, processing method, platelet activation and final fibrin characteristics can differ.

It may be considered for selected:

• Tendon disorders
• Partial tendon injuries
• Ligament-related conditions
• Symptomatic joint degeneration
• Periarticular soft-tissue problems
• Other clearly identified musculoskeletal targets

Activated PRF cannot guarantee:

• Complete tendon regeneration
• Restoration of all lost cartilage
• Permanent pain relief
• Prevention of future degeneration
• Avoidance of surgery

The expected benefit depends on the diagnosis, treatment target, structural condition and rehabilitation plan.

Read more about Activated PRF Therapy

Stem Cell and Cell-Based Therapy

“Stem cell therapy” is commonly used as a general marketing term, but cell-based treatments can differ substantially.

At Nucellin, autologous cell-based treatment may use a preparation obtained from the patient’s own:

• Peripheral blood
• Bone marrow
• Adipose tissue

These preparations are not biologically identical.

They differ in:

• Collection method
• Cell populations
• Processing method
• Procedural complexity
• Treatment purpose
• Available clinical evidence

The source and intended purpose should therefore be explained before treatment.

Blood-Derived Cell Therapy

Blood-derived cell therapy uses an autologous cellular preparation collected from the patient’s peripheral blood.

It is sometimes marketed under the broad term “blood stem cell therapy.” However, the exact cellular composition depends on the collection and processing method and should be explained clearly.

Blood-derived cell treatment is different from Activated PRF.

Activated PRF is primarily a platelet- and fibrin-based preparation. Blood-derived cell therapy uses a separate protocol intended to collect or concentrate selected circulating cellular fractions.

It may offer a less invasive collection process than bone marrow or adipose harvesting, but it is not automatically the right option for every condition.

Evidence for blood-derived musculoskeletal cell treatment remains more limited than the evidence available for some bone marrow- and adipose-derived applications.

Bone Marrow-Derived Cell Therapy

Bone marrow-derived treatment uses an autologous preparation collected from the patient’s bone marrow.

Bone marrow contains a mixture of:

• Haematopoietic cells
• Stromal progenitor cells
• Platelets
• Immune cells
• Other signalling components

Bone marrow concentrate is not a pure population of one type of stem cell.

The final composition depends on the collection site, aspiration technique, processing method and individual patient factors.

It may be considered for selected joint, cartilage-related or other musculoskeletal conditions.

Adipose-Derived Cell Therapy

Adipose-derived treatment uses an autologous cellular preparation obtained from the patient’s fat tissue.

Adipose tissue contains a heterogeneous mixture of stromal, vascular, immune and progenitor-cell populations.

It is biologically different from bone marrow- and blood-derived treatment and requires a separate harvesting procedure.

It may be considered for carefully selected patients with chronic degenerative joint or soft-tissue conditions.

What Cell-Based Treatment Can and Cannot Do

Cell-based treatment is intended to support the biologic environment rather than directly build a completely new joint.

Potential clinical goals may include:

• Reducing inflammatory overload
• Improving pain and function
• Supporting rehabilitation
• Improving tolerance for walking or exercise
• Delaying more invasive treatment when medically reasonable

It cannot guarantee:

• Restoration of a young and normal joint
• Regeneration of all lost cartilage
• Repair of a complete tendon rupture
• Correction of severe instability
• Reversal of major nerve compression
• Permanent pain relief
• Prevention of future surgery

The most complex treatment is not automatically the best treatment.

Read more about Stem Cell and Cell-Based Therapy

More detailed information about knee treatment is available on the Stem Cell Therapy for Knees page.

Shockwave Therapy

Shockwave therapy is not a cell treatment or an injection.

It uses externally delivered acoustic energy and may be considered for selected chronic tendon and accessible soft-tissue conditions.

At Nucellin, focused and radial shockwave therapy may serve different purposes.

• Focused shockwave may be directed toward a specific pain-generating tendon or soft-tissue target.
• Radial shockwave may be used across a broader overloaded muscle and fascial chain.

Shockwave therapy may be considered for selected conditions such as:

• Chronic tendinopathy
• Calcific tendon disorders
• Tendon insertion pain
• Chronic muscle and fascial overload
• Selected soft-tissue conditions

It does not repair a complete tendon rupture, restore major instability or replace necessary surgery.

Read more about Shockwave Therapy

Regenerative Physical Therapy

A biologic procedure cannot replace movement recovery.

Regenerative physical therapy may combine:

• Clinical reassessment
• Load modification
• Progressive strengthening
• Movement retraining
• Soft-tissue treatment
• Shockwave therapy
• High-intensity laser therapy
• Gradual return to activity

The purpose is to improve the capacity of the painful area and the wider movement system.

An injection may influence the local biologic environment. Rehabilitation determines how the tissue is loaded afterwards.

Read more about Regenerative Physical Therapy

Other Targeted Treatments

Selected patients may also benefit from image-guided treatment directed toward a specific joint, tendon, ligament, peripheral nerve or soft-tissue target.

PDRN-based or other regenerative injections may be considered when clinically appropriate.

These treatments are not separate solutions for every condition. Their role depends on:

• The diagnosis
• The target structure
• Previous treatment
• Imaging findings
• The patient’s medical history
• Expected benefits and limitations

Ultrasound or fluoroscopic guidance may be used depending on the target and procedure.

What Happens, Step by Step

1. Consultation

Dr. Heejun Kim personally evaluates each patient and can conduct the consultation in English.

He trained in orthopedic surgery at Severance Hospital and previously worked there as a Clinical Instructor.

The consultation includes review of:

• Symptoms
• Physical examination
• Functional limitations
• Previous treatment
• X-rays, MRI or ultrasound findings
• Medical history
• Activity goals
• Surgical indications

The first decision is not which procedure to perform.

It is whether regenerative treatment is appropriate at all.

2. Identification of the Pain Generator

A procedure should not be chosen simply because an MRI shows degeneration.

The proposed treatment target should reasonably match:

• The location of symptoms
• Movements that reproduce the pain
• Palpation and physical examination
• Strength and neurologic findings
• Imaging results
• Functional limitations

Sometimes the structure that looks most abnormal on imaging is not the structure producing the symptoms.

3. Selection of the Appropriate Treatment

The recommended treatment depends on:

• The diagnosis
• Stage of disease
• Tissue quality
• Mechanical stability
• General health
• Previous treatment
• Available evidence
• Recovery requirements
• Patient goals

The plan may involve:

• Rehabilitation alone
• Shockwave therapy
• Targeted injection treatment
• Activated PRF
• Blood-derived cell treatment
• Bone marrow-derived cell treatment
• Adipose-derived cell treatment
• Surgical referral

The most invasive treatment is not automatically the most effective.

4. Preparation and Procedure

The procedure varies according to the selected treatment.

Activated PRF

Blood is collected from a peripheral vein and prepared according to the Activated PRF protocol.

Blood-Derived Cell Treatment

Blood is collected and processed using the selected cellular preparation protocol.

Bone Marrow-Derived Treatment

Bone marrow is aspirated from an appropriate harvest site under sterile conditions and appropriate anaesthesia.

Adipose-Derived Treatment

Adipose tissue is collected through a separately planned harvesting procedure under sterile conditions and appropriate anaesthesia.

Image-Guided Delivery

When local treatment is planned, ultrasound or fluoroscopic guidance may be used to place the preparation accurately into the selected target.

5. Aftercare and Rehabilitation

The aftercare plan depends on the condition and procedure.

It may include:

• Temporary activity restriction
• Protection of the treated tissue
• Management of post-procedure soreness
• Gradual restoration of movement
• Progressive strengthening
• Load-management guidance
• Return-to-work or return-to-sport planning

General rest alone is not a rehabilitation plan.

The tissue must eventually learn to tolerate load again.

6. Follow-Up

Follow-up is arranged according to the diagnosis and treatment rather than one fixed schedule for every patient.

Reassessment may include:

• Pain and symptom review
• Range-of-motion testing
• Strength assessment
• Functional testing
• Review of rehabilitation
• Adjustment of the loading plan
• Repeat imaging when medically necessary

Recovery Timeline

There is no single recovery timeline for every regenerative treatment.

Shockwave therapy, Activated PRF, blood-derived cell treatment, bone marrow treatment and adipose-derived treatment involve different procedures and recovery requirements.

The following is a general framework rather than a guarantee.

The First Several Days

Depending on the procedure, patients may experience:

• Soreness at the treatment site
• Temporary swelling or joint irritation
• Soreness at a bone marrow or adipose harvest site
• Temporary reduction in activity

The degree of discomfort varies.

Weeks 1–6

The initial priorities may include:

• Protecting the treated tissue
• Maintaining safe movement
• Avoiding excessive load
• Gradually restoring daily activity
• Monitoring for complications

An immediate improvement is not required for the treatment to be considered potentially useful.

A lack of early improvement also does not guarantee that meaningful improvement will occur later.

Weeks 6–12

Rehabilitation may progress toward:

• Strength recovery
• Improved movement control
• Increased walking or exercise tolerance
• Gradual return to more demanding activity

This phase is important because a procedure alone does not restore tissue capacity.

Months 3–6

Where improvement occurs, it may become clearer over several months.

The degree and timing of response vary according to:

• The condition being treated
• Stage of structural damage
• Treatment performed
• General health
• Mechanical alignment and stability
• Rehabilitation participation
• Daily load

Recovery is not always linear, and no specific outcome can be guaranteed.

If You Are Travelling to Seoul

The number of days required in Seoul depends on:

• The selected treatment
• Whether blood, bone marrow or adipose harvesting is required
• The number of treatment sites
• Anaesthesia requirements
• The need for post-procedure review
• Your medical history
• Your flight schedule

Bone marrow- and adipose-derived procedures generally require more advance planning than a standard consultation, shockwave session or simple injection procedure.

The assessment, procedure schedule and travel plan should be agreed before flights and accommodation are booked.

Practical information is available on the International Patients page.

Whether It Suits You

Regenerative treatment may be considered when:

• Pain has continued despite appropriate conservative treatment
• A plausible pain generator has been identified
• Examination and imaging support the proposed target
• The condition is limiting meaningful daily function
• There is no urgent surgical indication
• The patient understands the available evidence and uncertainty
• The patient is willing to participate in rehabilitation
• Treatment goals are realistic

You May Be a Reasonable Candidate If

• You have chronic joint, tendon or ligament-related symptoms
• Appropriate rehabilitation has not provided sufficient improvement
• There is a clearly identified treatment target
• Surgery is not currently necessary or is not yet the preferred option
• You are willing to modify load and follow a rehabilitation plan
• You understand that improvement cannot be guaranteed

Regenerative Treatment May Not Be the Right Answer If

• There is no clear diagnosis or treatment target
• The condition is acutely unstable and requires protection first
• There is an active infection
• There is a suspected tumour
• There is a displaced fracture
• There is a complete tendon rupture requiring repair
• There is severe ligament instability
• There is progressive neurologic loss
• There is major spinal-cord or nerve compression
• Advanced joint destruction is more predictably treated with surgery
• You expect one procedure to reverse years of structural degeneration
• You cannot follow the required recovery and rehabilitation plan

Not every painful or worn joint needs regenerative treatment.

Some patients need stabilisation, rehabilitation, surgery or a change in daily load.

Premium care is not about offering the largest procedure.

It is about selecting the right level of treatment at the right time.

Risks and Limitations

Autologous treatment means that the preparation comes from the patient’s own body.

It does not mean that the procedure is risk-free.

Potential risks may include:

• Pain
• Swelling
• Bruising
• Bleeding
• Infection
• Temporary worsening of symptoms
• Nerve or blood-vessel injury
• Harvest-site discomfort
• Anaesthesia-related complications
• Failure to achieve meaningful improvement
• Need for additional treatment
• Need for future surgery

The specific risks depend on the treatment performed.

The expected benefits, uncertainties, alternatives and financial cost are discussed before treatment.

A Realistic View of Regenerative Medicine

Regenerative medicine cannot guarantee that damaged tissue will return to a young and completely normal state.

It cannot reliably reverse decades of degeneration.

It cannot correct every mechanical problem.

It cannot replace necessary surgery.

Realistic goals may include:

• Reducing local tissue irritation
• Improving pain
• Improving function
• Supporting rehabilitation
• Increasing tolerance for work, walking and exercise
• Treating a carefully identified musculoskeletal target
• Delaying more invasive treatment when medically reasonable

The goal is not to promise regeneration.

The goal is to determine whether improving the biologic and functional environment can produce a meaningful clinical benefit for the individual patient.

Questions Patients Ask

Is Regenerative Medicine the Same as Stem Cell Therapy?

No.

Stem cell and cell-based treatments are only one part of regenerative medicine.

The broader approach may also include Activated PRF, shockwave therapy, targeted injection treatment, rehabilitation and load management.

Can Regenerative Treatment Regrow Cartilage?

Current non-surgical treatments cannot reliably restore all lost cartilage or create a completely new joint.

Some treatments may improve pain, function or the biologic environment, but structural regeneration should not be guaranteed.

Is Activated PRF the Same as PRP?

No.

Both treatments are prepared from the patient’s blood, but the blood volume, processing method, activation process and final platelet-fibrin preparation may differ.

The exact protocol matters.

Is Blood-Derived Cell Therapy the Same as Activated PRF?

No.

Activated PRF is primarily a platelet- and fibrin-based treatment.

Blood-derived cell therapy uses a different collection and processing protocol intended to obtain a cellular preparation from peripheral blood.

The exact cell composition should be explained before treatment.

Which Cell Source Is Best?

There is no single best source for every patient.

The decision between blood-, bone marrow- and adipose-derived treatment depends on:

• Diagnosis
• Stage of disease
• Treatment target
• General health
• Procedural complexity
• Available evidence
• Recovery requirements
• Patient goals

A more complex procedure is not automatically more effective.

Do I Need an MRI Before Treatment?

Not every patient needs MRI.

The need for imaging depends on the symptoms, physical examination, existing X-rays or ultrasound and whether the result would change the treatment plan.

Nucellin Orthopedic Clinic does not have an on-site MRI scanner. When MRI is medically appropriate, imaging can be arranged at a nearby radiology centre and reviewed with you.

Can Regenerative Treatment Prevent Surgery?

It may help some selected patients improve function or delay more invasive treatment.

It cannot guarantee that surgery will never be needed.

When surgery is likely to provide the safer or more predictable result, this should be discussed honestly.

How Long Do I Need to Stay in Seoul?

The required stay depends on the procedure.

A consultation, shockwave session or selected injection may require a relatively short visit. Bone marrow- and adipose-derived treatments require separate planning and may require a longer stay.

The recommended schedule is confirmed before treatment is booked.

International Patients

International patients can consult directly with Dr. Kim in English.

You may send or bring:

• X-rays
• MRI images
• Ultrasound images
• Medical reports
• Previous treatment records
• Current medication information

Imaging is reviewed together with symptoms and physical examination rather than interpreted in isolation.

Cell-based procedures require individual planning. The recommended treatment, number of days in Seoul, recovery plan and written estimate are discussed before the procedure.

Information about insurance and payment is available on the Insurance & Payment page.

To arrange an evaluation, please contact the clinic.

Start with an informed medical assessment, not a procedure.